.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Fish and Richardson
US Department of Justice
Teva
AstraZeneca
Chubb
McKinsey
Mallinckrodt
Johnson and Johnson
Dow

Generated: February 20, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Australia Patent: PO 8640

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-001Jan 23, 2012RXYesYes➤ Try a Free Trial➤ Try a Free TrialTREATMENT OF ACTINIC KERATOSIS
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-002Jan 23, 2012RXYesYes➤ Try a Free Trial➤ Try a Free TrialTREATMENT OF ACTINIC KERATOSIS
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-001Jan 23, 2012RXYesYes➤ Try a Free Trial➤ Try a Free TrialTO STIMULATE THE IMMUNE SYSTEM TO INDUCE T CELL PROLIFERATION
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-002Jan 23, 2012RXYesYes➤ Try a Free Trial➤ Try a Free TrialTO STIMULATE THE IMMUNE SYSTEM TO INDUCE T CELL PROLIFERATION
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-001Jan 23, 2012RXYesYes➤ Try a Free Trial➤ Try a Free TrialTO INHIBIT THE PROLIFERATIVE ACTIVITY OF NEOPLASTIC CELLS
Leo LabsPICATOingenol mebutateGEL;TOPICAL202833-002Jan 23, 2012RXYesYes➤ Try a Free Trial➤ Try a Free TrialTO INHIBIT THE PROLIFERATIVE ACTIVITY OF NEOPLASTIC CELLS
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist